Position in IRON
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,549,278
+$3,521,805 QoQ
Shares Held
75,872
+139.3% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#60
of 216 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in IRON Over Time
Shares Held
Position Value (USD)
Derivatives in IRON
reported options exposure · as of Dec 31, 2024CallValue
$951,000
CallShares
15,000
PutValue
$951,000
PutShares
15,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. IRON ranks #50 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in IRON
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,549,278 | 75,872 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,027,473 | 31,709 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,251,025 | 15,754 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $355,312 | 5,377 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $951,000 | 15,000 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $951,000 | 15,000 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $432,677 | 8,805 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $468,260 | 8,107 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $244,296 | 5,200 | Shares | Defined | 2023-11-14 | |
| 2021-12-31 GMTX | — | 14,829 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||